Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

    NEXT STORY
    Colorectal Cancer Therapeutics Market to reach USD 16.58 billion by 2026, Presence of Strong Oncology Portfolio to help Players Gain Competitive: Reports Fortune Business Insights™
    PREV STORY
    Global Women’s Health Diagnostics Market, Forecast to 2025 – Leading Players are General Electric; Abbott Labs; Siemens; Becton, Dickinson & Co; and Quest Diagnostics
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

    ROCKVILLE, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a ...

    author_avatar
    NASDAQ Market News

    MediWound Successfully Completes Second Cohort of EscharEx® Phase 2 Study

    YAVNE, Israel, Sept. 01, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    SELLAS Appoints Steering Committee of Leading Acute Myeloid Leukemia Experts for Its Ongoing Phase 3 REGAL Clinical Trial in AML

    author_avatar
    NASDAQ Market News